|
|
Volumn 185, Issue 6, 2011, Pages 2156-2157
|
|
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: A randomised open-label trial
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CABAZITAXEL;
DOCETAXEL;
MITOXANTRONE;
PREDNISONE;
ANTINEOPLASTIC ACTIVITY;
CANCER GROWTH;
CANCER MORTALITY;
CANCER RESISTANCE;
CANCER SURVIVAL;
CASTRATION;
COMPARATIVE EFFECTIVENESS;
CONTROLLED STUDY;
DIARRHEA;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG FATALITY;
DRUG HYPERSENSITIVITY;
DRUG SAFETY;
FEBRILE NEUTROPENIA;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
METASTASIS;
NEUTROPENIA;
NOTE;
OVERALL SURVIVAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROGRESSION FREE SURVIVAL;
PROSTATE CANCER;
RANDOMIZATION;
RANDOMIZED CONTROLLED TRIAL;
|
|
EID: 79955804457
PISSN: 00225347
EISSN: None
Source Type: Journal
DOI: 10.1016/S0022-5347(11)60262-0 Document Type: Note |
|
Times cited : (4)
|
|
References (1)
|
